Details for New Drug Application (NDA): 018885
✉ Email this page to a colleague
The generic ingredient in EMBOLEX is dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride profile page.
Summary for 018885
Tradename: | EMBOLEX |
Applicant: | Novartis |
Ingredient: | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/0.5ML;2,500 UNITS/0.5ML;5.33MG/0.5ML | ||||
Approval Date: | Nov 30, 1984 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/0.7ML;5,000 UNITS/0.7ML;7.46MG/0.7ML | ||||
Approval Date: | Nov 30, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018885
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-002 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-002 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription